🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase IIa, randomized, multi-site, two-arm, double-blinded ...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03-27
Trial ID
NCT02076178
Treatments Being Tested
This is an active control, randomized study to investigate the safety, tole...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-07-31
Trial ID
NCT04484337
The CAPRISA 014 trial aims to assess the safety and acceptability of the lo...
Status
Withdrawn
Location
CAPRISA eThekwini Research Clinic
Start Date
2015-10
Trial ID
NCT02462772
Treatments Being Tested
The study is designed to select a dose of GSK1265744 primarily on the basis...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-06
Trial ID
NCT01641809
A single dose escalation study to determine the safety, tolerability, and p...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01756131
Treatments Being Tested
This study is being conducted to comply with the Food and Drug Administrati...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-01
Trial ID
NCT02027454
Treatments Being Tested
The purpose of this randomized, double-blinded study is to test the safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-09
Trial ID
NCT00920426
Treatments Being Tested